UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

ANEBULO PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

Securities to be registered pursuant to Section 12(b) of the Act:

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. [X]

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. [  ]

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. [  ]

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-254979

Securities to be registered pursuant to Section 12(g) of the Act:

The information required by this Item is included under the captions “Description of Capital Stock” (pages 92 - 95), “ Dividend Policy” (page 48) and “Shares Eligible for Future Sale” (pages 96 - 97) of the Prospectus included as part of the Registrant’s Registration Statement on Form S-1, Registration No. 333-254979 (“Form S-1”), which information is incorporated herein by this reference.

The following documents are included as exhibits to Form S-1, as indicated, and are incorporated herein by this reference:

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

EXHIBIT INDEX

The following documents are included as exhibits to the Registrant’s Registration Statement on Form S-1, Registration No. 333-254979, to be declared effective on May 6, 2021 (“Form S-1”), as indicated, and are incorporated herein by this reference: